AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
AEON Biopharma, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.23−0.00 (-0.43%)
Close on Oct 19, 2026
- Market cap
- $11.67M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
25.7%
13M of 50M shares
Institutional holders
22
2 new, 4 sold out
Net institutional buying
10M
In Q2 2026
Insider trades, 12 months
1 buys · 0 sales
Net bought $241.50K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Stonepine Capital, L.P. | 6,892,682 | 9.90% | 13G (passive) | Jul 15, 2026 |
| Timothy P. Lynch | 6,500,000 | 13.00% | 13G (passive) | Aug 19, 2026 |
| Bigger Michael | 4,900,000 | 6.10% | 13G (passive) | Jan 6, 2025 |
| Robert J Palmisano | 2,265,000 | 5.70% | 13D (active) | Jul 25, 2024 |
| The Palmisano Family, LLC | 2,265,000 | 5.70% | 13D (active) amendment | Jul 25, 2024 |
| Daewoong Pharmaceutical Co. Ltd ("DWP") | 12,009,737 | 49.75% | 13D (active) | Jan 21, 2026 |
| Chernett Jorey | 1,128,500 | 9.90% | 13G (passive) | May 27, 2025 |
| Dauntless Investment Group, LLC | 108,224 | 9.70% | 13G (passive) | Feb 26, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AEON | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Dauntless Investment Group, LLC | 12,490,154 | 25.04% | $8.98M | +9,962,379 | 7.06% |
| Geode Capital Management, LLC | 95,311 | 0.19% | $68.56K | +8,249 | 0.00% |
| Vanguard Capital Management LLC | 90,529 | 0.18% | $65.09K | – | 0.00% |
| Blue Owl Capital Holdings LP | 42,353 | 0.08% | $30.49K | – | 0.00% |
| Formidable Asset Management, LLC | 20,024 | 0.04% | $19.72K | – | 0.00% |
| StoneX Group Inc. | 18,953 | 0.04% | $14.94K | New | 0.00% |
| Vanguard Fiduciary Trust Co | 13,713 | 0.03% | $9.86K | −989 | 0.00% |
| LPL Financial LLC | 11,507 | 0.02% | $8.28K | – | 0.00% |
| Citigroup Inc | 7,315 | 0.01% | $5.26K | +6,573 | 0.00% |
| UBS Group AG | 5,062 | 0.01% | $3.64K | +880 | 0.00% |
| BlackRock, Inc. | 2,834 | 0.01% | $2.04K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 2,567 | 0.01% | $1.85K | +2,097 | 0.00% |
| Steward Partners Investment Advisory, LLC | 1,100 | 0.00% | $791 | – | 0.00% |
| Wolff Wiese Magana LLC | 567 | 0.00% | $408 | – | 0.00% |
| SBI Securities Co., Ltd. | 232 | 0.00% | $167 | +127 | 0.00% |
| Dupont Capital Management Corp | 170 | 0.00% | $122 | – | 0.01% |
| Morgan Stanley | 150 | 0.00% | $108 | – | 0.00% |
| GHP Investment Advisors, Inc. | 95 | 0.00% | $69 | – | 0.00% |
| Wells Fargo & Company/Mn | 90 | 0.00% | $65 | – | 0.00% |
| Barclays PLC | 59 | 0.00% | $42 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 22 | 13M | 25.7% | 2 / 6 | 1 / 4 | 10M | 0M |
| Q1 2026 | 24 | 3M | 5.7% | 9 / 4 | 2 / 5 | 1M | 0M |
| Q4 2025 | 22 | 2M | 4.9% | 4 / 8 | 1 / 3 | 1M | 0M |
| Q3 2025 | 21 | 1M | 2.7% | 5 / 2 | 3 / 2 | 0M | 0M |
| Q2 2025 | 18 | 1M | 2.5% | 3 / 4 | 1 / 1 | 0M | 0M |
| Q1 2025 | 16 | 2M | 3.1% | 16 / 0 | 0 / 0 | 2M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of AEON | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 90,529 | 0.18% | $65.12K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 47,535 | 0.10% | $35.97K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 11,192 | 0.02% | $8.47K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 3,072 | 0.01% | $2.32K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Robert E. Bancroft | PRESIDENT & CEO, Director | 3,177,103 | 6.37% | Feb 19, 2026 |
| John Bencich | CHIEF FINANCIAL OFFICER | 754,717 | 1.51% | Apr 3, 2026 |
| Chad Oh | CHIEF MEDICAL OFFICER | 2,183,436 | 4.38% | Mar 11, 2026 |
| Alexander Blair Wilson | CLO, CSO, and Corp Secretary | 2,183,005 | 4.38% | Mar 5, 2026 |
| Jennifer Sy | PRINCIPAL ACCOUNTING OFFICER | 1,501,176 | 3.01% | Mar 5, 2026 |
| Robert J. Palmisano | Director | 2,523,705 | 5.06% | Jun 22, 2026 |
| Marc Forth | Director | 973,231 | 1.95% | Jun 22, 2026 |
| Shelley B. Thunen | Director | 258,705 | 0.52% | Jun 22, 2026 |
| Jost Fischer | Director | 489,469 | 0.98% | Jun 22, 2026 |
| Eric G. Carter | Director | 258,705 | 0.52% | Jun 22, 2026 |
| Timothy P. Lynch | 10% owner | 6,500,000 | 13.03% | Aug 21, 2026 |
| Daewoong Co., Ltd | 10% owner | 12,009,737 | 24.08% | Jan 29, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Timothy P. Lynch 10% owner | Aug 19, 2026 | Buy | +1,150,000 | $0.21 | $241.50K | 6,500,000 |
| Shelley B. Thunen Director | Jun 17, 2026 | Award | +222,684 | – | – | 258,705 |
| Eric G. Carter Director | Jun 17, 2026 | Award | +222,684 | – | – | 258,705 |
| Jost Fischer Director | Jun 17, 2026 | Award | +222,684 | – | – | 489,469 |
| Marc Forth Director | Jun 17, 2026 | Award | +222,684 | – | – | 973,231 |
| Robert J. Palmisano Director | Jun 17, 2026 | Award | +222,684 | – | – | 258,705 |
| John Bencich CHIEF FINANCIAL OFFICER | Apr 2, 2026 | Award | +754,717 | – | – | 754,717 |
| Chad Oh CHIEF MEDICAL OFFICER | Mar 4, 2026 | Award | +1,316,872 | – | – | 2,183,436 |
| Jennifer Sy PRINCIPAL ACCOUNTING OFFICER | Mar 4, 2026 | Award | +925,925 | – | – | 1,501,176 |
| Alexander Blair Wilson CLO, CSO, and Corp Secretary | Mar 4, 2026 | Award | +1,316,872 | – | – | 2,183,005 |
| Chad Oh CHIEF MEDICAL OFFICER | Feb 17, 2026 | Award | +862,500 | – | – | 866,564 |
| Jennifer Sy PRINCIPAL ACCOUNTING OFFICER | Feb 17, 2026 | Award | +575,000 | – | – | 575,251 |
| Alexander Blair Wilson CLO, CSO, and Corp Secretary | Feb 17, 2026 | Award | +862,500 | – | – | 866,133 |
| Robert E. Bancroft PRESIDENT & CEO, Director | Feb 17, 2026 | Award | +3,000,000 | – | – | 3,177,103 |
| Jost Fischer Director | May 21, 2025 | Buy | +60,000 | $0.49 | $29.40K | 266,785 |
| Jost Fischer Director | May 20, 2025 | Buy | +60,000 | $0.51 | $30.60K | 206,785 |
| Jost Fischer Director | May 19, 2025 | Buy | +50,000 | $0.50 | $25.00K | 146,785 |
| Robert E. Bancroft President & CEO, Director | May 14, 2025 | Award | +177,103 | – | – | 177,103 |
| Robert J. Palmisano Director | Aug 31, 2024 | Award | +36,021 | – | – | 36,021 |
| Robert J. Palmisano Director | Aug 31, 2024 | Award | +36,021 | – | – | 36,021 |
| Marc Forth CHIEF EXECTUIVE OFFICER, Director | Aug 31, 2024 | Award | +470,692 | – | – | 750,547 |
| Jost Fischer Director | Aug 31, 2024 | Award | +36,021 | – | – | 96,785 |
| Alexander Blair Wilson EXEC VP, CLO & CORP SECRETARY | Aug 31, 2024 | Award | +180,110 | – | – | 261,538 |
| Shelley B. Thunen Director | Aug 31, 2024 | Award | +36,021 | – | – | 36,021 |
| Jennifer Sy PRINCIPAL ACCOUNTING OFFICER | Aug 31, 2024 | Award | +18,010 | – | – | 18,010 |
| Eric G. Carter Director | Aug 31, 2024 | Award | +36,021 | – | – | 36,021 |
| Chad Oh CHIEF MEDICAL OFFICER | Aug 31, 2024 | Award | +192,117 | – | – | 292,545 |
| Strathspey Crown Holdings Group, LLC 10% owner | Aug 11, 2023 | Sale | −7,380,394 | $10.00 | $73.80M | 2,031,773 |
| Oleg Grodnensky 10% owner | Jul 21, 2023 | Conversion | +89,163 | – | – | 6,989,163 |
| Oleg Grodnensky 10% owner | Jul 21, 2023 | Conversion | +6,900,000 | – | – | 6,900,000 |
| Jost Fischer Director | Jul 21, 2023 | Award | +2,353 | – | – | 2,353 |
| Jost Fischer Director | Jul 21, 2023 | Award | +13,274 | – | – | 13,274 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Grodnensky Oleg Affiliate | Jul 29, 2024 | 201,825 | $530.78K | Jul 29, 2024 | Exercise of Warrants 03/29/2024 |